Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.

Neoplasia · 2016 · PMC5018094 · PMID 27566105

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

In a Cox multivariate analysis including clinicopathologic variables, PCAT14 stands out as a significant independent predictor of PSS ( P = .0385; HR = 0.55 [0.31–0.97]), MFS ( P = .000609; HR = 0.52[0.36–0.76]) and BRFS ( P = .00126, HR = 0.64 [0.49–0.84]), with borderline significance for OS ( Table 1 , Supplementary Table 3 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.